Schedule 13D ownership disclosure

Shattuck Labs Inc

Common Stock, par value $0.0001 per share · CUSIP: 82024L103

Event date: 2025-08-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Redmile Group, LLCReported CIK 0001425738

    Shares: 5,652,660.00 · Class: 11.8%

  • Jeremy C. GreenReported CIK 0001650527

    Shares: 5,652,660.00 · Class: 11.8%

  • Redmile Biopharma Investments II, L.P.Reported CIK 0001772230

    Shares: 3,338,997.00 · Class: 7.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-074849
Form type
SCHEDULE 13D/A
Filer
Redmile Group, LLC
CIK
CIK 1425738
Filed
Aug 06, 2025
Reporting period
Aug 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub